心脏再同步治疗患者的碘-间碘苄胍显像：结果引人关注，但仍存在未知因素。 - Suppr

Suppr

超能文献

I-meta-Iodobenzylguanidine Imaging in Patients with Cardiac Resynchronization Therapy: Results are Intriguing, but Unknowns Remain.

作者信息

Doytchinova Anisiia, Gerson Myron C

机构信息

Division of Cardiovascular Health and Disease, University of Cincinnati Medical Center, Cincinnati, OH, USA.

出版信息

J Nucl Cardiol. 2020 Feb;27(1):291-293. doi: 10.1007/s12350-018-1381-x. Epub 2018 Aug 1.

DOI:10.1007/s12350-018-1381-x

PMID:30069822

Abstract

摘要

相似文献

I-meta-Iodobenzylguanidine Imaging in Patients with Cardiac Resynchronization Therapy: Results are Intriguing, but Unknowns Remain.心脏再同步治疗患者的碘-间碘苄胍显像：结果引人关注，但仍存在未知因素。

J Nucl Cardiol. 2020 Feb;27(1):291-293. doi: 10.1007/s12350-018-1381-x. Epub 2018 Aug 1.

Neuronal damage and abnormal contraction: Is the circle of synchronicity complete?神经元损伤与异常收缩：同步性循环是否完整？

J Nucl Cardiol. 2019 Jun;26(3):880-882. doi: 10.1007/s12350-017-1167-6. Epub 2018 Jan 11.

Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.心肌碘-123 间碘苄胍显像与心力衰竭中的心脏事件。前瞻性 ADMIRE-HF（AdreView 心肌成像用于心力衰竭风险评估）研究的结果。

J Am Coll Cardiol. 2010 May 18;55(20):2212-21. doi: 10.1016/j.jacc.2010.01.014. Epub 2010 Feb 25.

[123 I-MIBG scintigraphy in the assessment of heart failure prognosis and effectiveness of cardiac resynchronization therapy].[123I-间碘苄胍闪烁显像在心力衰竭预后评估及心脏再同步治疗疗效评估中的应用]

Kardiologiia. 2019 Nov 4;60(2):122-130. doi: 10.18087/cardio.2020.2.n324.

Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure.心脏碘-123 间碘苄胍显像对提高慢性心力衰竭患者西雅图心力衰竭模型预后能力的作用。

Am J Cardiol. 2011 Apr 15;107(8):1185-90. doi: 10.1016/j.amjcard.2010.12.019. Epub 2011 Feb 23.

Re: Improvement in cardiac sympathetic nerve activity in responders to resynchronization therapy.

Europace. 2008 Jul;10(7):892; author reply 892-3. doi: 10.1093/europace/eun133. Epub 2008 May 21.

The relation between cardiac 123I-mIBG scintigraphy and functional response 1 year after CRT implantation.心脏 123I-mIBG 闪烁显像与 CRT 植入后 1 年时功能反应的关系。

Eur Heart J Cardiovasc Imaging. 2021 Jan 1;22(1):49-57. doi: 10.1093/ehjci/jeaa045.

(123)I-mIBG imaging predicts functional improvement and clinical outcome in patients with heart failure and CRT implantation.（123）I-间碘苄胍显像可预测心力衰竭合并心脏再同步化治疗植入患者的功能改善情况及临床结局。

Int J Cardiol. 2016 Mar 15;207:107-9. doi: 10.1016/j.ijcard.2016.01.131. Epub 2016 Jan 9.

Prognostic effect and modulation of cardiac sympathetic function in heart failure patients treated with cardiac resynchronization therapy.心脏再同步治疗心力衰竭患者心脏自主神经功能的预后影响及调节。

J Nucl Cardiol. 2020 Feb;27(1):283-290. doi: 10.1007/s12350-018-1357-x. Epub 2018 Jul 10.

[Value of cardiac scintigraphy with I123 meta-iodobenzylguanidine in congestive heart failure. A review].[I123间碘苄胍心脏闪烁显像在充血性心力衰竭中的价值。综述]

Ann Cardiol Angeiol (Paris). 1997 May-Jun;46(5-6):293-302.

本文引用的文献

Indications for Cardiac Resynchronization Therapy: A Comparison of the Major International Guidelines.心脏再同步治疗适应证：主要国际指南比较。

JACC Heart Fail. 2018 Apr;6(4):308-316. doi: 10.1016/j.jchf.2018.01.022.

Validation of 2-year 123I-meta-iodobenzylguanidine-based cardiac mortality risk model in chronic heart failure.基于 123I-间碘苄胍的 2 年心脏死亡率风险模型在慢性心力衰竭中的验证。

Eur Heart J Cardiovasc Imaging. 2018 Jul 1;19(7):749-756. doi: 10.1093/ehjci/jey016.

Reliability of the I-mIBG heart/mediastinum ratio: Results of a multicenter test-retest reproducibility study.I-mIBG 心脏/纵隔比值的可靠性：多中心测试-再测试可重复性研究的结果。

J Nucl Cardiol. 2019 Oct;26(5):1555-1565. doi: 10.1007/s12350-017-1183-6. Epub 2018 Jan 17.

Relationship of left ventricular global longitudinal strain with cardiac autonomic denervation as assessed by I-mIBG scintigraphy in patients with heart failure with reduced ejection fraction submitted to cardiac resynchronization therapy : Assessment of cardiac autonomic denervation by GLS in patients with heart failure with reduced ejection fraction submitted to CRT.左心室整体纵向应变与心脏自主神经去神经支配的关系：评估接受心脏再同步治疗的射血分数降低心力衰竭患者的心脏自主神经去神经支配

J Nucl Cardiol. 2019 Jun;26(3):869-879. doi: 10.1007/s12350-017-1148-9. Epub 2017 Dec 5.

Determination of the Heart-to-Mediastinum Ratio of I-MIBG Uptake Using Dual-Isotope (I-MIBG/Tc-Tetrofosmin) Multipinhole Cadmium-Zinc-Telluride SPECT in Patients with Heart Failure.使用双同位素（I-MIBG/Tc- 替曲膦）多针孔碲化镉锌探测器 SPECT 测定心力衰竭患者的 I-MIBG 摄取的心脏-纵隔比。

J Nucl Med. 2018 Feb;59(2):251-258. doi: 10.2967/jnumed.117.194373. Epub 2017 Jun 23.

Cardiac sympathetic nervous system imaging with I-meta-iodobenzylguanidine: Perspectives from Japan and Europe.用I-间碘苄胍进行心脏交感神经系统成像：来自日本和欧洲的观点。

J Nucl Cardiol. 2017 Jun;24(3):952-960. doi: 10.1007/s12350-017-0818-y. Epub 2017 Mar 13.

Creation of mortality risk charts using 123I meta-iodobenzylguanidine heart-to-mediastinum ratio in patients with heart failure: 2- and 5-year risk models.利用123I间碘苄胍心脏与纵隔比值创建心力衰竭患者死亡风险图表：2年和5年风险模型

Eur Heart J Cardiovasc Imaging. 2016 Oct;17(10):1138-45. doi: 10.1093/ehjci/jev322. Epub 2015 Dec 24.

Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in Japan.心脏 123I-MIBG 成像在临床决策中的应用：日本 22 年的经验。

J Nucl Med. 2015 Jun;56 Suppl 4:11S-19S. doi: 10.2967/jnumed.114.142794.

20 years of cardiac resynchronization therapy.20 年心脏再同步治疗。

J Am Coll Cardiol. 2014 Sep 9;64(10):1047-58. doi: 10.1016/j.jacc.2014.06.1178.

For what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis.对于慢性心力衰竭患者，心肌123I-MIBG闪烁扫描术对何种终点具有最大的预后价值？一项汇总个体患者数据的荟萃分析结果

Eur Heart J Cardiovasc Imaging. 2014 Sep;15(9):996-1003. doi: 10.1093/ehjci/jeu044. Epub 2014 Mar 30.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验